Reference : Metabolomics in toxicology and preclinical research.
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
http://hdl.handle.net/10993/32230
Metabolomics in toxicology and preclinical research.
English
Ramirez, Tzutzuy [> >]
Daneshian, Mardas [> >]
Kamp, Hennicke [> >]
Bois, Frederic Y. [> >]
Clench, Malcolm R. [> >]
Coen, Muireann [> >]
Donley, Beth [> >]
Fischer, Steven M. [> >]
Ekman, Drew R. [> >]
Fabian, Eric [> >]
Guillou, Claude [> >]
Heuer, Joachim [> >]
Hogberg, Helena T. [> >]
Jungnickel, Harald [> >]
Keun, Hector C. [> >]
Krennrich, Gerhard [> >]
Krupp, Eckart [> >]
Luch, Andreas [> >]
Noor, Fozia mailto [Saarland University > Biochemical Engineering]
Peter, Erik [> >]
Riefke, Bjoern [> >]
Seymour, Mark [> >]
Skinner, Nigel [> >]
Smirnova, Lena [> >]
Verheij, Elwin [> >]
Wagner, Silvia [> >]
Hartung, Thomas [> >]
van Ravenzwaay, Bennard [> >]
Leist, Marcel [> >]
2013
ALTEX: Alternativen zu Tierexperimenten
30
2
209-25
Yes
International
1868-596X
Germany
[en] Animals ; Humans ; Metabolomics/methods ; Models, Biological ; Predictive Value of Tests ; Reproducibility of Results ; Toxicity Tests/methods
[en] Metabolomics, the comprehensive analysis of metabolites in a biological system, provides detailed information about the biochemical/physiological status of a biological system, and about the changes caused by chemicals. Metabolomics analysis is used in many fields, ranging from the analysis of the physiological status of genetically modified organisms in safety science to the evaluation of human health conditions. In toxicology, metabolomics is the -omics discipline that is most closely related to classical knowledge of disturbed biochemical pathways. It allows rapid identification of the potential targets of a hazardous compound. It can give information on target organs and often can help to improve our understanding regarding the mode-of-action of a given compound. Such insights aid the discovery of biomarkers that either indicate pathophysiological conditions or help the monitoring of the efficacy of drug therapies. The first toxicological applications of metabolomics were for mechanistic research, but different ways to use the technology in a regulatory context are being explored. Ideally, further progress in that direction will position the metabolomics approach to address the challenges of toxicology of the 21st century. To address these issues, scientists from academia, industry, and regulatory bodies came together in a workshop to discuss the current status of applied metabolomics and its potential in the safety assessment of compounds. We report here on the conclusions of three working groups addressing questions regarding 1) metabolomics for in vitro studies 2) the appropriate use of metabolomics in systems toxicology, and 3) use of metabolomics in a regulatory context.
http://hdl.handle.net/10993/32230

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.